(Q74460233)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Silbermann S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Weller S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Kirschke R

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Körholz D

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Janssen G

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Göbel U

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Nürnberger W

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

259-264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535993%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703136

10 November 2019

exact match

0 references

cites work

In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Granulocyte colony-stimulating factor potentiates anti-Candida albicans growth inhibitory activity of polymorphonuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Structural Characterization of Natural and Recombinant Human Granulocyte Colony-Stimulating Factors1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Influence of the carbohydrate moiety on the stability of glycoproteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Cysteine 17 of recombinant human granulocyte-colony stimulating factor is partially solvent-exposed.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

The international standard for granulocyte colony stimulating factor (G-CSF). Evaluation in an international collaborative study. Participants of the Collaborative Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Three types of recombinant human granulocyte colony-stimulating factor have equivalent biological activities in monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy volunteers--a comparative study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Crossover study of the haematological effects and pharmacokinetics of glycosylated and non-glycosylated G-CSF in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Flow cytometry comparison of CD34+ subsets in bone marrow and peripheral blood after priming with glycosylated or non-glycosylated rhG-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Mobilization kinetics of CD34(+) cells in association with modulation of CD44 and CD31 expression during continuous intravenous administration of G-CSF in normal donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021

The clinical utility of granulocyte colony-stimulating factor: early achievements and future promise

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703136

7 January 2021